Does the IRB charge for review of industry sponsored clinical research?
A. Universities are now charging a fee to commercial/industry sponsors of clinical research for IRB-related expenses. This is either a single flat fee, or a fee for initial review and continuing review. The funds generated by this fee are used to support the IRB and related expenses (e.g. educational initiatives). The industry sponsors are accustomed to this as an expected fee for clinical research projects. University policy specified that budgets for commercially funded clinical projects should include a one-time fee of $2,000, listed as “IRB Review Fee”. ORI sends a separate invoice to the company for this fee and the income will be deposited in an account other than the grant account. This fee is separate from any start-up costs that the department may apply or any costs incurred through CRDOC. As we seek to accelerate UK’s clinical research activities it is important that we have strong, well-supported systems for the protection of the individuals who participate in that research.
